These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9491877)

  • 21. Postmenopausal estrogen use among African American and white patients at an urban clinic.
    Jahnige K; Fiebach N
    J Womens Health; 1997 Feb; 6(1):93-101. PubMed ID: 9065378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: The Kame Project.
    Rice MM; Graves AB; McCurry SM; Gibbons LE; Bowen JD; McCormick WC; Larson EB
    Arch Intern Med; 2000 Jun; 160(11):1641-9. PubMed ID: 10847257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative hormone therapy trials.
    Maalouf NM; Sato AH; Welch BJ; Howard BV; Cochrane BB; Sakhaee K; Robbins JA
    Arch Intern Med; 2010 Oct; 170(18):1678-85. PubMed ID: 20937929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen replacement therapy is underutilized among postmenopausal women at high risk for coronary heart disease.
    Massey CV; Hupp CH; Kreisberg M; Alpert MA; Hoff C
    Am J Med Sci; 2000 Aug; 320(2):124-7. PubMed ID: 10981488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
    Speroff L
    Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does hormone therapy counter the beneficial effects of physical activity on breast cancer risk in postmenopausal women?
    Dieli-Conwright CM; Sullivan-Halley J; Patel A; Press M; Malone K; Ursin G; Burkman R; Strom B; Simon M; Weiss L; Marchbanks P; Folger S; Spirtas R; Deapen D; Bernstein L
    Cancer Causes Control; 2011 Mar; 22(3):515-22. PubMed ID: 21213036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of prior hysterectomy as an independent predictor of Framingham risk score (The Women's Health Initiative).
    Hsia J; Barad D; Margolis K; Rodabough R; McGovern PG; Limacher MC; Oberman A; Smoller S;
    Am J Cardiol; 2003 Aug; 92(3):264-9. PubMed ID: 12888128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
    Barber CA; Margolis K; Luepker RV; Arnett DK
    J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duration of menopausal vasomotor symptoms over the menopause transition.
    Avis NE; Crawford SL; Greendale G; Bromberger JT; Everson-Rose SA; Gold EB; Hess R; Joffe H; Kravitz HM; Tepper PG; Thurston RC;
    JAMA Intern Med; 2015 Apr; 175(4):531-9. PubMed ID: 25686030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of postmenopausal hormone replacement therapy by African American women. The importance of physician discussion.
    McNagny SE; Jacobson TA
    Arch Intern Med; 1997 Jun; 157(12):1337-42. PubMed ID: 9201008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlates of postmenopausal female hormone use among black women in the United States.
    Ransom SA; Sauer HJ
    Obstet Gynecol; 1998 Jul; 92(1):159-60. PubMed ID: 9649114
    [No Abstract]   [Full Text] [Related]  

  • 34. Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women.
    Norman SA; Berlin JA; Weber AL; Strom BL; Daling JR; Weiss LK; Marchbanks PA; Bernstein L; Voigt LF; McDonald JA; Ursin G; Liff JM; Burkman RT; Malone KE; Simon MS; Folger SG; Deapen D; Wingo PA; Spirtas R
    Cancer Causes Control; 2003 Dec; 14(10):933-43. PubMed ID: 14750532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Premenopausal Hysterectomy and Risk of Ovarian Cancer in African-American Women.
    Peres LC; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy M; Cote ML; Funkhouser E; Moorman PG; Peters ES; Schwartz AG; Terry PD; Abbott SE; Camacho F; Wang F; Schildkraut JM
    Am J Epidemiol; 2017 Jul; 186(1):46-53. PubMed ID: 28444120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials.
    Wild RA; Wu C; Curb JD; Martin LW; Phillips L; Stefanick M; Trevisan M; Manson JE
    Menopause; 2013 Mar; 20(3):254-60. PubMed ID: 23435021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hysterectomy status, estrogen use and quality of life in older women: the Rancho Bernardo study.
    Kritz-Silverstein D; Von Muhlen DG; Ganiats TG; Barrett-Connor E
    Qual Life Res; 2004 Feb; 13(1):55-62. PubMed ID: 15058787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
    Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postmenopausal hormone therapy and migraine headache.
    Misakian AL; Langer RD; Bensenor IM; Cook NR; Manson JE; Buring JE; Rexrode KM
    J Womens Health (Larchmt); 2003 Dec; 12(10):1027-36. PubMed ID: 14709191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and characteristics associated with use of hormone replacement therapy in Britain.
    Moorhead T; Hannaford P; Warskyj M
    Br J Obstet Gynaecol; 1997 Mar; 104(3):290-7. PubMed ID: 9091004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.